Insights into mast cell functions in asthma using mouse models

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2013, Pages 532-539

  Lei, Ying ^a   Gregory, Joshua A ^a   Nilsson, Gunnar P ^a   Adner, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Airway hyperresponsiveness; Engraftement; Inflammation; Mast cells; Mouse asthma models

Indexed keywords

ALLERGIC AIRWAY INFLAMMATION; ASTHMA; BRONCHOSPASM; BRONCHUS MUSCLE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL RESEARCH; DISEASE MODEL; ENGRAFTMENT; EXPERIMENTAL GUINEA PIG; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ALVEOLUS CELL; MAST CELL; NONHUMAN; PARENCHYMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; SENSITIZATION; SMOOTH MUSCLE FIBER; VASODILATATION;

AIRWAY HYPERRESPONSIVENESS; ENGRAFTEMENT; INFLAMMATION; MAST CELLS; MOUSE ASTHMA MODELS;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MAST CELLS; MICE; SPECIES SPECIFICITY;

EID: 84882722397     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.03.019     Document Type: Review

References (75)

1. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
2. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012, 18:716-725.
3. Wenzel S.E., Larsen G.L., Johnston K., Voelkel N.F., Westcott J.Y. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990, 142:112-119.
4. Bradding P., Walls A.F., Holgate S.T. The role of the mast cell in the pathophysiology of asthma. JAllergy Clin Immunol 2006, 117:1277-1284.
5. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nat Med 2012, 18:693-704.
6. Peachell P. Targeting the mast cell in asthma. Curr Opin Pharmacol 2005, 5:251-256.
7. Nagai H. Recent research and developmental strategy of anti-asthma drugs. Pharmacol Ther 2012, 133:70-78.
8. Krug N., Rabe K.F. Animal models for human asthma: the perspective of a clinician. Curr Drug Targets 2008, 9:438-442.
9. Kirshenbaum A.S., Goff J.P., Kessler S.W., Mican J.M., Zsebo K.M., Metcalfe D.D. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. JImmunol 1992, 148:772-777.
10. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739.
11. Nilsson G., Alving K., Ahlstedt S., Hokfelt T., Lundberg J.M. Peptidergic innervation of rat lymphoid tissue and lung: relation to mast cells and sensitivity to capsaicin and immunization. Cell Tissue Res 1990, 262:125-133.
12. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 2004, 4:787-799.
13. Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 1986, 83:4464-4468.
14. Andersson C.K., Mori M., Bjermer L., Lofdahl C.G., Erjefalt J.S. Novel site-specific mast cell subpopulations in the human lung. Thorax 2009, 64:297-305.
15. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988, 137:62-69.
16. Carroll N.G., Mutavdzic S., James A.L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002, 19:879-885.
17. Balzar S., Fajt M.L., Comhair S.A., Erzurum S.C., Bleecker E., Busse W.W., et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am J Respir Crit Care Med 2011, 183:299-309.
18. Andersson C.K., Bergqvist A., Mori M., Mauad T., Bjermer L., Erjefalt J.S. Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. JAllergy Clin Immunol 2011, 127:905-912. e1-7.
19. Elliot J.G., Abramson M.J., Drummer O.H., Walters E.H., James A.L. Time to death and mast cell degranulation in fatal asthma. Respirology 2009, 14:808-813.
20. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. NEngl J Med 2002, 346:1699-1705.
21. James A., Gyllfors P., Henriksson E., Dahlen S.E., Adner M., Nilsson G., et al. Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi. Allergy 2012, 67:958-961.
22. Hallstrand T.S., Moody M.W., Wurfel M.M., Schwartz L.B., Henderson W.R., Aitken M.L. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005, 172:679-686.
23. Hallstrand T.S., Wurfel M.M., Lai Y., Ni Z., Gelb M.H., Altemeier W.A., et al. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes. PLoS One 2010, 5:e8583.
24. Xing W., Austen K.F., Gurish M.F., Jones T.G. Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue. Proc Natl Acad Sci U S A 2011, 108:14210-14215.
25. Bachelet C.M., Bernaudin J.F., Fleury-Feith J. Distribution and histochemical characterization of pulmonary mast cells in the rat and guinea pig. Int Arch Allergy Appl Immunol 1988, 87:225-229.
26. Szelenyi I. Animal models of bronchial asthma. Inflamm Res 2000, 49:639-654.
27. Fernandez-Rodriguez S., Broadley K.J., Ford W.R., Kidd E.J. Increased muscarinic receptor activity of airway smooth muscle isolated from a mouse model of allergic asthma. Pulm Pharmacol Ther 2010, 23:300-307.
28. Moffatt J.D., Cocks T.M., Page C.P. Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br J Pharmacol 2004, 141:1159-1166.
29. Roquet A., Dahlen B., Kumlin M., Ihre E., Anstren G., Binks S., et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997, 155:1856-1863.
30. Sundstrom E., Lastbom L., Ryrfeldt A., Dahlen S.E. Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung. JPharmacol Exp Ther 2003, 307:408-418.
31. Curzen N., Rafferty P., Holgate S.T. Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. Thorax 1987, 42:946-952.
32. Ghanem N.S., Assem E.S., Leung K.B., Pearce F.L. Guinea pig mast cells: comparative study on morphology, fixation and staining properties. Int Arch Allergy Appl Immunol 1988, 85:351-357.
33. Canning B.J., Chou Y. Using guinea pigs in studies relevant to asthma and COPD. Pulm Pharmacol Ther 2008, 21:702-720.
34. Stevenson C.S., Birrell M.A. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol Ther 2011, 130:93-105.
35. Ikeda R.K., Miller M., Nayar J., Walker L., Cho J.Y., McElwain K., et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. JImmunol 2003, 171:4860-4867.
36. Pae S., Cho J.Y., Dayan S., Miller M., Pemberton A.D., Broide D.H. Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics 2010, 62:499-506.
37. Williams C.M., Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. JExp Med 2000, 192:455-462.
38. Swedin L., Ellis R., Neimert-Andersson T., Ryrfeldt A., Nilsson G., Inman M., et al. Prostaglandin modulation of airway inflammation and hyperresponsiveness in mice sensitized without adjuvant. Prostag Other Lipid Mediat 2010, 92:44-53.
39. Brewer J.P., Kisselgof A.B., Martin T.R. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 1999, 160:1150-1156.
40. Whitehead G.S., Walker J.K., Berman K.G., Foster W.M., Schwartz D.A. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 2003, 285:L32-L42.
41. Swedin L., Ellis R., Kemi C., Ryrfeldt A., Inman M., Dahlen S.E., et al. Comparison of aerosol and intranasal challenge in a mouse model of allergic airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 2010, 153:249-258.
42. Safholm J., Lovdahl C., Swedin L., Boels P.J., Dahlen S.E., Arner A., et al. Inflammation-induced airway smooth muscle responsiveness is strain dependent in mice. Pulm Pharmacol Ther 2011.
43. Geissler E.N., Ryan M.A., Housman D.E. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988, 55:185-192.
44. Galli S.J., Kitamura Y. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses invivo. Am J Pathol 1987, 127:191-198.
45. Kitamura Y., Go S., Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978, 52:447-452.
46. Kitamura Y., Go S. Decreased production of mast cells in S1/S1d anemic mice. Blood 1979, 53:492-497.
47. Berrozpe G., Timokhina I., Yukl S., Tajima Y., Ono M., Zelenetz A.D., et al. The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 1999, 94:2658-2666.
48. Grimbaldeston M.A., Chen C.C., Piliponsky A.M., Tsai M., Tam S.Y., Galli S.J. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology invivo. Am J Pathol 2005, 167:835-848.
49. Wolters P.J., Mallen-St Clair J., Lewis C.C., Villalta S.A., Baluk P., Erle D.J., et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 2005, 35:82-88.
50. Reber L.L., Marichal T., Galli S.J. New models for analyzing mast cell functions invivo. Trends Immunol 2012, 33:613-625.
51. Feyerabend T.B., Weiser A., Tietz A., Stassen M., Harris N., Kopf M., et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011, 35:832-844.
52. Dudeck A., Dudeck J., Scholten J., Petzold A., Surianarayanan S., Kohler A., et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011, 34:973-984.
53. Lilla J.N., Chen C.C., Mukai K., BenBarak M.J., Franco C.B., Kalesnikoff J., et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 2011, 118:6930-6938.
54. Sawaguchi M., Tanaka S., Nakatani Y., Harada Y., Mukai K., Matsunaga Y., et al. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. JImmunol 2012, 188:1809-1818.
55. Waern I., Jonasson S., Hjoberg J., Bucht A., Abrink M., Pejler G., et al. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. JImmunol 2009, 183:6369-6376.
56. Katz H.R., Austen K.F. Mast cell deficiency, a game of kit and mouse. Immunity 2011, 35:668-670.
57. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. JExp Med 1985, 162:1025-1043.
58. Martin T.R., Takeishi T., Katz H.R., Austen K.F., Drazen J.M., Galli S.J. Mast cell activation enhances airway responsiveness to methacholine in the mouse. JClin Invest 1993, 91:1176-1182.
59. Fuchs B., Sjoberg L., Moller Westerberg C., Ekoff M., Swedin L., Dahlen S.E., et al. Mast cell engraftment of the peripheral lung enhances airway hyperresponsiveness in a mouse asthma model. Am J Physiol Lung Cell Mol Physiol 2012.
60. Becker M., Reuter S., Friedrich P., Doener F., Michel A., Bopp T., et al. Genetic variation determines mast cell functions in experimental asthma. JImmunol 2011, 186:7225-7231.
61. Masuda T., Tanaka H., Komai M., Nagao K., Ishizaki M., Kajiwara D., et al. Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin Exp Allergy 2003, 33:705-713.
62. Ogawa K., Kaminuma O., Kikkawa H., Nakata A., Asahina M., Egan R.W., et al. Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness. Clin Exp Allergy 2002, 32:140-148.
63. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. JImmunol 2000, 164:3855-3861.
64. Reuter S., Heinz A., Sieren M., Wiewrodt R., Gelfand E.W., Stassen M., et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J 2008, 31:773-782.
65. Taube C., Wei X., Swasey C.H., Joetham A., Zarini S., Lively T., et al. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. JImmunol 2004, 172:6398-6406.
66. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. JClin Invest 2006, 116:1633-1641.
67. Chai O.H., Han E.H., Lee H.K., Song C.H. Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-alpha. Exp Mol Med 2011, 43:35-43.
68. Kim Y.S., Ko H.M., Kang N.I., Song C.H., Zhang X., Chung W.C., et al. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma. Eur J Immunol 2007, 37:1107-1115.
69. Jin C., Shelburne C.P., Li G., Potts E.N., Riebe K.J., Sempowski G.D., et al. Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. JClin Invest 2011, 121:941-955.
70. Gersch C., Dewald O., Zoerlein M., Michael L.H., Entman M.L., Frangogiannis N.G. Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol 2002, 118:41-49.
71. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol Rev 2004, 84:1341-1379.
72. Yu M., Eckart M.R., Morgan A.A., Mukai K., Butte A.J., Tsai M., et al. Identification of an IFN-gamma/mast cell axis in a mouse model of chronic asthma. JClin Invest 2011, 121:3133-3143.
73. Holmes A.M., Solari R., Holgate S.T. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 2011, 16:659-670.
74. Evans R.L., Nials A.T., Knowles R.G., Kidd E.J., Ford W.R., Broadley K.J. Acomparison of antiasthma drugs between acute and chronic ovalbumin-challenged guinea-pig models of asthma. Pulm Pharmacol Ther 2012.
75. Corry D.B., Grunig G., Hadeiba H., Kurup V.P., Warnock M.L., Sheppard D., et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998, 4:344-355.